Parietal lobe ependymoma is a rare brain tumor that starts in cells linked to the lining of the brain’s fluid spaces. Early symptoms of parietal lobe ependymoma can include headaches, seizures, nausea, and trouble with sensation, attention, reading, or judging where things are in space. Parietal lobe ependymoma can affect both children and adults, and symptoms may build over days to months as the tumor grows. Not everyone will have the same experience, but the outlook depends on the tumor’s size, grade, location, and how fully it can be removed, and some cases can be life-threatening. Treatment for parietal lobe ependymoma usually includes surgery and may also include radiation therapy, while chemotherapy is used in some situations.
How many people live with Parietal lobe ependymoma?
Exact worldwide and U.S. numbers for people living with parietal lobe ependymoma are not available from a single trusted source. This is because major brain tumor registries usually count ependymoma as a whole rare brain tumor, rather than separately tracking the much smaller group of tumors that are specifically in the parietal lobe.
Overview
Parietal lobe ependymomaSymptoms
Parietal lobe ependymoma can cause headaches, seizures, and nausea from pressure in the brain. Many living with parietal lobe ependymoma also notice vision changes, numbness, weakness, or trouble with reading, writing, or spatial awareness.
Outlook and prognosis
Parietal lobe ependymoma outlook depends on tumor grade, whether surgeons can remove it fully, and response to radiation. Many living with parietal lobe ependymoma do well after treatment, but careful long-term brain scans and follow-up remain important.
Causes and risk factors
Parietal lobe ependymoma usually has no clear cause. Most cases happen sporadically, but rare inherited conditions such as neurofibromatosis type 2 and prior radiation to the head can raise risk. No lifestyle factor is known to directly cause parietal lobe ependymoma.
Genetic influences
Genetics matter in parietal lobe ependymoma, but most cases are not clearly inherited. Many are linked to DNA changes that arise in the tumor itself, and these can help guide diagnosis, outlook, and sometimes treatment choices.
Diagnosis
Parietal lobe ependymoma is diagnosed using brain imaging, usually MRI and sometimes CT, to locate the tumor. Doctors confirm the diagnosis of parietal lobe ependymoma by examining tumor tissue after surgery or biopsy.
Treatment and drugs
Treatment for parietal lobe ependymoma usually involves surgery to remove as much of the tumor as is safely possible, followed by radiation if needed. Some people also need chemotherapy, especially children or if the tumor returns.
Symptoms
Parietal lobe ependymoma can affect how you sense space, use an arm or leg, or process touch, reading, and numbers. Because this tumor grows in a part of the brain that helps combine sensory information, symptoms often reflect both its location and pressure inside the skull. Symptoms vary from person to person and can change over time. Some people first notice headaches or seizures, while others notice subtle trouble judging distance, finding their way around a room, or using one side of the body.
Headaches can be one of the early symptoms of parietal lobe ependymoma, especially if they are worse in the morning or when bending over, coughing, or straining. Nausea and vomiting can happen when the tumor raises pressure inside the skull.
Some people with parietal lobe ependymoma have seizures, which may cause jerking, staring spells, unusual sensations, or brief loss of awareness. Sometimes a seizure is the first sign that leads to brain imaging.
The tumor can cause weakness, clumsiness, or numbness, often on one side of the body. This may show up as dropping objects, a heavy-feeling arm or leg, or trouble with buttons and writing.
Many living with parietal lobe ependymoma have trouble judging distance, locating objects, or moving through space smoothly. Day to day, it can feel like bumping into doorways, misreaching for a cup, or getting turned around in familiar places.
How people usually first notice Parietal lobe ependymoma?
People usually first notice parietal lobe ependymoma through symptoms that build quietly and then start interfering with daily life, such as headaches, nausea, vomiting, or seizures, especially as pressure inside the skull rises. Because the parietal lobe helps process sensation and spatial awareness, the first signs of parietal lobe ependymoma can also include numbness or tingling on one side of the body, weakness, trouble judging where your body is in space, clumsiness, or difficulty with reading, writing, or simple math. In some people the change is sudden enough to bring them to urgent care after a seizure, while in others it is first noticed as a pattern of persistent, worsening neurologic symptoms that prompts brain imaging.
Types of Parietal lobe ependymoma
Parietal lobe ependymoma can vary in how fast it grows and how it behaves under the microscope, which is why doctors talk about different types of parietal lobe ependymoma rather than one single pattern. In day-to-day life, these differences may affect how quickly symptoms build up, from subtle trouble with reading, writing, or spatial awareness to headaches or seizures. Not everyone will experience every type.
Classic ependymoma
This is the more typical form and often grows more slowly than higher-grade tumors. Many people with classic parietal lobe ependymoma develop symptoms gradually, such as headaches, seizures, weakness on one side, or trouble judging space and position. Because the parietal lobe helps process sensation and spatial awareness, some may also notice numbness or problems with reading, writing, or math.
Anaplastic ependymoma
This higher-grade form tends to grow faster and is more likely to cause symptoms over a shorter period of time. People living with anaplastic parietal lobe ependymoma may have more intense headaches, more frequent seizures, or quicker changes in thinking, sensation, or movement. Swelling around the tumor can also make symptoms feel more sudden or severe.
Subependymoma
This is a rarer, usually slow-growing variant that may cause few symptoms at first. When it does cause problems, they often come on gradually and may include headaches or seizures, especially if the tumor becomes large enough to press on nearby brain tissue. Some are found by chance on brain imaging done for another reason.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of symptoms from a parietal lobe ependymoma, a rare brain tumor. Unlike some other health problems, this tumor is not known to be prevented by diet, exercise, sleep, or supplements, and there is no routine screening or preventive medicine for people without symptoms, though research is still ongoing. The most useful step is to have new problems such as ongoing headaches, seizures, weakness, numbness, or trouble with balance or awareness checked early, which can help people get diagnosed and treated sooner even if it does not prevent the tumor.
What genetics can tell you about symptoms
For people with parietal lobe ependymoma, genetics can sometimes help doctors understand how the tumor may behave, but day-to-day symptoms are usually shaped more by where the tumor is in the brain and how much pressure it causes than by inherited DNA. Certain tumor gene changes and molecular subtypes are linked with differences in when the tumor tends to appear, how fast it may grow, and sometimes how serious symptoms become, but they do not predict symptoms with certainty. In most cases, these tumors are not passed down in families, so genetic testing is usually used more to classify the tumor and guide care than to explain exactly which symptoms someone will have.
Causes and risk factors
The exact causes and risk factors for parietal lobe ependymoma are not fully understood. Most cases seem to start from gene changes that happen during life in cells that line spaces in the brain. A small number are linked to rare inherited conditions such as neurofibromatosis type 2, and age can also affect who is more likely to develop certain types. Not everyone with the same risk develops the condition. No clear lifestyle or environmental risk factors have been proven for parietal lobe ependymoma, so everyday habits are not known to be a direct cause.
What are the most common causes or risk factors?
In most people with parietal lobe ependymoma, there is no clear cause, and it is not linked to anything you or your parents did. These tumors are thought to start when cells in the brain pick up gene changes by chance, and the best-known risk factor is a rare inherited condition called neurofibromatosis type 2, which can raise the chance of some nervous system tumors. Brain ependymomas are also seen more often in children than in adults, and past radiation to the head may play a role in a small number of cases.
Environmental and biological risk factors
Parietal lobe ependymoma is a rare brain tumor, and in most cases there is no single clear cause. Doctors often group risks into internal (biological) and external (environmental). The known risk factors for parietal lobe ependymoma are limited, with younger age and past exposure to ionizing radiation being the best-established ones.
Ependymoma in the brain is seen more often in children than in adults, although it can happen at any age. This makes younger age one of the main biological patterns linked with parietal lobe ependymoma.
Previous exposure to ionizing radiation, especially radiation treatment to the head or nearby areas, can raise the chance of developing a later brain tumor. This is uncommon, but it is one of the clearest environmental risks associated with ependymoma.
Genetic risk factors
When a brain tumor like parietal lobe ependymoma appears, families often want to know whether it was inherited. In most cases, parietal lobe ependymoma is linked to DNA changes that arise only in the tumor itself, not changes passed down through a family. Carrying a genetic change doesn’t guarantee the condition will appear, but understanding the genetic causes of parietal lobe ependymoma can help explain why tumor testing is often part of care.
Sporadic changes: Most cases are tied to gene changes that happen in the tumor after conception, rather than in every cell of the body. This means the change usually was not inherited and usually cannot be passed on to children.
ZFTA fusion: Many ependymomas in the upper part of the brain, including some in the parietal lobe, are driven by a gene fusion called ZFTA. This fusion can keep growth signals switched on, making it one of the best-known genetic causes of parietal lobe ependymoma.
YAP1 fusion: A smaller group of supratentorial ependymomas, often in younger children, has a YAP1 gene fusion instead. These tumors are genetically distinct, so lab testing helps doctors sort them into the right subtype.
Inherited syndromes: Rarely, an inherited condition such as neurofibromatosis type 2 can increase the chance of developing an ependymoma. This is uncommon in parietal lobe ependymoma, and most people with this tumor do not have a known family syndrome.
Family history: A clear family history of ependymoma is unusual. If several relatives have nervous system tumors or a known inherited syndrome, genetic counseling may help clarify whether inherited testing is worth discussing.
Lifestyle risk factors
There are no clearly proven lifestyle habits that directly cause parietal lobe ependymoma. In practice, discussions about how lifestyle affects parietal lobe ependymoma focus more on symptom burden, recovery, and complication management during and after treatment. Diet, activity, sleep, and substance use can still matter because they may influence seizures, fatigue, wound healing, and tolerance of surgery, radiation, or chemotherapy.
Gentle, regular movement can help reduce deconditioning, fatigue, and loss of function after surgery or during radiation treatment. Exercise plans often need to be adapted for weakness, balance problems, visual-spatial deficits, or seizure risk related to a parietal lobe tumor.
Poor appetite, weight loss, or inadequate protein intake can slow healing and make treatment side effects harder to tolerate. Balanced nutrition and good hydration may support strength, recovery, and steroid-related blood sugar control.
Irregular or poor-quality sleep can worsen fatigue, concentration problems, headaches, and seizure threshold. A consistent sleep routine may help with day-to-day cognitive function and symptom management.
Heavy alcohol use and non-prescribed drug use can interfere with antiseizure medicines, worsen cognition, and increase fall or seizure risk. Avoiding these substances is especially important when the tumor or its treatment already affects brain function.
Risk prevention
There is no sure way to prevent parietal lobe ependymoma, and most people who develop it did nothing to cause it. Prevention is about lowering risk, not eliminating it completely. The clearest known avoidable risk is unnecessary radiation exposure to the head, especially earlier in life, while people with rare inherited risk factors may benefit from personalized medical advice.
Avoid imaging tests that use radiation unless they are truly needed, and ask whether a non-radiation option such as MRI could work instead. This matters most for repeated head imaging and for radiation treatments to the brain, which are used only when the medical benefit clearly outweighs the risk.
Most parietal lobe ependymoma cases are not inherited, but a small number are linked to rare genetic conditions. If several close relatives have had brain or nerve tumors, genetic counseling may help clarify whether extra monitoring makes sense.
Learning the early symptoms of parietal lobe ependymoma cannot prevent the tumor itself, but it can help people seek care sooner if one develops. Persistent headaches, seizures, weakness, numbness, or trouble with spatial tasks and reading deserve medical attention, especially if they are new or worsening.
People who have had prior radiation to the head or a past brain tumor may need long-term follow-up with their care team. Prevention works best when combined with regular check-ups, because new symptoms or changes can be assessed without delay.
Can you prevent Parietal lobe ependymoma?
No, there is no proven way to prevent parietal lobe ependymoma, a rare tumor that starts in the brain. In most cases, it happens without a clear cause, and there are no well-established lifestyle changes known to stop it from developing.
Transmission
Parietal lobe ependymoma is not an infection, so it cannot be caught from another person and is not contagious. Living with someone who has it, sharing food, or providing care does not put you at risk of developing it.
When people ask how parietal lobe ependymoma is inherited, the answer is that it is usually not passed from parent to child. Most cases seem to happen because of gene changes that develop in the tumor cells during life, and only rarely is there an underlying inherited condition that raises the risk.
When to test your genes
For parietal lobe ependymoma, routine inherited gene testing is not usually recommended for early detection because most cases are not passed down in families. Genetic or molecular testing matters most after diagnosis, when tumor testing can refine the subtype and help guide treatment. Consider genetic counseling if there is a strong family history of brain tumors or related cancers.
Diagnosis
Parietal lobe ependymoma is usually diagnosed after symptoms such as headaches, seizures, weakness, numbness, or trouble with spatial awareness lead to a medical evaluation. It’s natural to worry when symptoms don’t have a clear explanation. The diagnosis of parietal lobe ependymoma usually combines a brain exam, imaging scans, and testing of tumor tissue after surgery or biopsy.
Doctors ask about when symptoms started, how they have changed, and whether there have been seizures, headaches, vision changes, or problems with balance and coordination. They also do a neurologic exam to check strength, sensation, reflexes, speech, and how well different parts of the brain are working.
MRI is the main scan used to look for a parietal lobe ependymoma and see its size, exact location, and effect on nearby brain tissue. Contrast dye is often used to make the tumor stand out more clearly and to help with surgical planning.
A CT scan may be done quickly in urgent situations, especially if there is concern about bleeding, swelling, or fluid buildup in the brain. It is less detailed than MRI for tumor features, but it can help guide early care.
A definite diagnosis usually requires a sample of the tumor taken during surgery or, less often, a biopsy. A pathologist examines the cells under a microscope to confirm that the tumor is an ependymoma and to assess its grade.
How is Parietal lobe ependymoma diagnosed?
Parietal lobe ependymoma is usually suspected after symptoms lead to a medical checkup, including questions about changes such as headaches, seizures, weakness, numbness, vision problems, or trouble with thinking, reading, or finding your way around, followed by a brain scan, most often an MRI and sometimes a CT scan. The diagnosis is confirmed by surgery or a biopsy, which means taking some or all of the tumor and examining it under a microscope. In some cases, extra lab tests on the tumor, including genetic testing, help define the exact type and guide treatment.
Stages of Parietal lobe ependymoma
Parietal lobe ependymoma does not have defined progression stages. This is because it is usually described by where the tumor is, how it looks on scans and under the microscope, and whether it is growing or causing symptoms, rather than by a step-by-step pattern over time. Often the process begins when you notice changes in daily life, such as headaches, seizures, trouble with balance, or problems judging space, and these can overlap with the early symptoms of parietal lobe ependymoma. Doctors usually diagnose and monitor parietal lobe ependymoma with brain imaging, especially MRI scans, along with a neurologic exam and, in most cases, testing of tumor tissue after surgery or biopsy.
Outlook and prognosis
Outlook for a parietal lobe ependymoma depends mainly on tumor grade, whether it can be completely removed, the person’s age, and whether the tumor returns after treatment. In general, patients with a well-circumscribed, lower-grade supratentorial ependymoma that is fully resected tend to have a favorable prognosis, while higher-grade tumors or those with residual disease after surgery carry a higher risk of recurrence and a worse outlook. Radiation therapy often improves local control when complete resection is not possible, but long-term follow-up is important because ependymomas can recur years later. Reported survival varies across studies, but overall 5-year survival for supratentorial ependymoma is often in the roughly 50% to 80% range, with better outcomes in lower-grade cases and poorer outcomes in anaplastic disease. Mortality is driven mainly by progressive or recurrent tumor and complications related to the tumor’s location or treatment. Because parietal lobe tumors may sometimes be more surgically accessible than those in deeper or brainstem locations, some patients achieve prolonged disease control, especially with complete resection and appropriate adjuvant therapy.
Long-term effects
For many people, the long-term effects of parietal lobe ependymoma depend on the tumor’s size and location, whether it comes back, and how much treatment is needed. Because this part of the brain helps with sensation, spatial awareness, reading, writing, and some aspects of movement, daily tasks can still feel different even after treatment ends. It’s important to remember that long-term doesn’t always mean progressive. Some changes improve with time, while others can last for years and need ongoing follow-up.
Some people have lasting trouble with attention, processing speed, planning, or short-term memory. This can show up as taking longer to follow a conversation, organize tasks, or switch between activities at work or school.
The parietal lobe helps the brain judge where the body is in space, so some may find reaching, dressing, driving, or navigating crowded places harder. Problems with judging distance, bumping into objects, or missing part of what is around them can persist after parietal lobe ependymoma.
Numbness, tingling, or reduced awareness of touch on one side of the body can last if nearby brain tissue was affected. Some people also notice trouble recognizing where an arm or leg is without looking at it, which can affect balance and coordination.
Weakness or clumsiness on one side can continue, especially if the tumor or surgery affected nearby pathways that help control movement. For many, symptoms are mild but still noticeable during fine motor tasks like buttoning clothes, writing, or using utensils.
How is it to live with Parietal lobe ependymoma?
Living with a parietal lobe ependymoma often means coping not only with the stress of having a brain tumor, but also with changes in how you sense space, pay attention, read, write, or coordinate everyday tasks. For many people, this can affect work, school, driving, and independence, and symptoms such as headaches, seizures, fatigue, or weakness can make even ordinary routines feel less predictable. Family members and other close supporters are often drawn into appointments, treatment decisions, and day-to-day help, which can be emotionally and practically demanding, but with rehabilitation, symptom treatment, and steady support, many people find ways to adapt and regain confidence in daily life.
Treatment and drugs
Treatment for parietal lobe ependymoma usually centers on surgery to remove as much of the tumor as safely possible, because the growth sits in a part of the brain that helps with sensation, spatial awareness, and tasks like reading, writing, or finding your way around. After surgery, doctors often use MRI scans and the tumor’s lab results to decide whether radiation therapy is needed, especially if some tumor remains or if the ependymoma has features linked with a higher chance of coming back. Not every treatment works the same way for every person, and chemotherapy is not the main treatment for most parietal lobe ependymoma cases, though it may be considered in some children, in recurrent disease, or when surgery and radiation are not enough. Alongside medical treatment, rehabilitation such as physical, occupational, speech, or vision therapy can be an important part of recovery if the tumor or surgery affects movement, coordination, school or work tasks, or other early symptoms of parietal lobe ependymoma.
Can you cure Parietal lobe ependymoma?
Sometimes, yes, but it depends on how aggressive the tumor is, where it is in the brain, and whether doctors can safely remove all of it. For some people living with a parietal lobe ependymoma, surgery and often radiation can get rid of the tumor for a long time and may lead to a cure. If a full cure is not possible or the tumor comes back, treatment can still help control the tumor and ease symptoms.
Non-drug treatment
Living with a parietal lobe ependymoma can affect day-to-day tasks in ways that feel surprisingly practical, like judging where your arm is when reaching for a cup, reading a page without losing your place, or noticing weakness on one side. Treatment usually centers on removing or controlling the tumor and then helping the brain recover skills that may have been disrupted. For many, treatment begins not at the pharmacy, but with surgery, radiation, and rehabilitation tailored to the part of the brain involved. Because this tumor sits in an area that helps process sensation, space, and attention, support often includes therapy for balance, movement, thinking, and the early symptoms of parietal lobe ependymoma.
Surgery is often the main non-drug treatment for parietal lobe ependymoma. The goal is to remove as much of the tumor as can be done safely while protecting nearby brain tissue that helps with sensation, movement, and spatial awareness.
Radiation may be used after surgery if some tumor remains or if the tumor has features that raise the risk of it coming back. It aims focused energy at tumor cells while the care team works to limit effects on healthy brain tissue.
Physical therapy can help if the tumor or surgery affects balance, coordination, walking, or strength. Many people with parietal lobe ependymoma use it to feel steadier getting out of bed, climbing stairs, or moving through busy spaces.
Occupational therapy focuses on everyday tasks such as dressing, bathing, cooking, writing, and using a phone or keyboard. It can also help with problems judging position, handling objects, or paying attention to one side of the body.
Your genes may have an impact on how drugs work for you
For people living with parietal lobe ependymoma, treatment is usually centered on surgery and often radiation, so inherited gene differences are usually not the main factor deciding care. Still, these differences can affect how some supportive medicines work, such as pain relievers, anti-seizure medicines, or medicines used to help with swelling, which may mean one person gets good relief while another has more side effects or needs a different dose. In some cases, doctors may use this kind of gene-based medicine matching, called pharmacogenomics, to help choose or adjust these drugs, but it is not a standard part of treatment for everyone with this tumor.
Pharmacological treatments
For parietal lobe ependymoma, medicines are often used to control symptoms or in some cases to treat tumor growth when surgery and radiation are not enough. There is no single standard drug that reliably cures parietal lobe ependymoma, and the drug plan often depends on age, tumor grade, location, and whether the tumor has come back. Some medicines work quickly, while others are mainly considered for recurrent parietal lobe ependymoma or when other treatments are not possible. Not everyone responds to the same medication in the same way.
Dexamethasone is a steroid often used to reduce brain swelling around the tumor. This can ease headaches, nausea, weakness, or pressure symptoms while other treatment is being planned or after surgery.
Levetiracetam is commonly used if parietal lobe ependymoma causes seizures, and other options include lacosamide or lamotrigine. These drugs do not treat the tumor itself, but they can help prevent seizure episodes that disrupt daily life.
Temozolomide is an oral chemotherapy drug that may be used for some recurrent ependymomas, especially when standard options have been exhausted. Its benefit can be limited, but it is sometimes chosen because it is easier to take than hospital-based chemotherapy.
Cisplatin or carboplatin may be combined with etoposide, cyclophosphamide, or vincristine in children or adults with recurrent disease. These chemotherapy combinations are not routine first-line treatment for ependymoma, but they may be used when the tumor returns or cannot be fully removed.
Genetic influences
When parietal lobe ependymoma is diagnosed, many families want to know whether it was inherited. It’s natural to ask whether family history plays a role. In most people, parietal lobe ependymoma is not passed down through a family; instead, it is usually driven by DNA changes that arise in the tumor cells during life. Because these tumors are in the upper part of the brain, doctors often test the tumor for specific gene joins, called fusions, especially ZFTA and less often YAP1, since these findings can help confirm the tumor type and sometimes give clues about outlook. Rare inherited conditions can increase the chance of developing an ependymoma, but this is uncommon, and most families will not have a clear inherited cause. If the age at diagnosis, tumor features, or family history raise questions, genetic testing for parietal lobe ependymoma and genetic counseling can help sort out whether the change is limited to the tumor or could matter for relatives too.
Is Parietal lobe ependymoma genetic?
Genetics matter in parietal lobe ependymoma, but most cases are not clearly inherited. Many are linked to DNA changes that arise in the tumor itself, and these can help guide diagnosis, outlook, and sometimes treatment choices.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are common and are a normal part of human biology. Most do not have a direct effect on health and simply reflect the natural differences seen among people. For many genes, having a variant linked with a condition suggests a possible connection rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-understood variant in a particular gene is enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
For people with parietal lobe ependymoma, genetics most often influences treatment by helping doctors understand the tumor’s subtype, how likely it is to come back, and whether a clinical trial might be a good fit. In practice, this means tissue removed during surgery is often tested for changes in the tumor cells, because some genetic patterns are linked with more aggressive behavior while others suggest a different outlook. Beyond trial and error, genetics offers another way to personalize care, even though surgery and radiation are still the main treatments for most parietal lobe ependymomas. Right now, there are no widely used standard medicines chosen only by a person’s inherited genes for this tumor, and chemotherapy has a more limited, case-by-case role than it does for many other cancers. Genetic testing for parietal lobe ependymoma treatment may also help identify research studies of newer targeted drugs, especially if the tumor returns or does not respond as hoped. For many living with parietal lobe ependymoma, this means genetics can guide decisions and expectations, but it does not yet replace the need for careful imaging, surgery, and follow-up care.
Interactions with other conditions
For many living with parietal lobe ependymoma, day-to-day problems are not always caused by the tumor alone. Seizures, ongoing headaches, weakness, vision-spatial trouble, or thinking changes can overlap with conditions such as epilepsy, migraine, stroke, or other brain disorders, which can make the early symptoms of parietal lobe ependymoma harder to recognize. Doctors call it a comorbidity when two conditions occur together. A parietal lobe ependymoma can also lead to fluid buildup in the brain, known as hydrocephalus, and this may worsen balance problems, nausea, or confusion, especially in people who already have other neurologic illness. In some cases, treatment-related effects can interact with other health issues too, such as fatigue being worse in someone with anemia or memory problems being more noticeable in people already living with depression or anxiety. Because these overlaps can look different from person to person, careful follow-up helps doctors sort out what is coming from the tumor, what may be due to another condition, and what needs urgent attention.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Parietal lobe ependymoma?
Symptoms of a parietal lobe ependymoma can look a lot like those caused by other brain tumors, including glioma, meningioma, or cancer that has spread to the brain. Stroke, bleeding in the brain, and a brain abscess, which is a pocket of infection, can also cause similar problems such as headaches, seizures, weakness, numbness, or trouble judging where things are in space. Because these problems can overlap so much, brain scans are usually needed to tell them apart.
History
When a brain tumor affects the parietal lobe, daily life can change in subtle but unsettling ways. Someone may start bumping into doorframes on one side, struggle to judge where their hand is reaching, or find that reading, writing, or doing simple number tasks suddenly feels harder. A parietal lobe ependymoma is one possible cause, and its history is closely tied to the broader story of how doctors came to recognize ependymomas as a distinct group of tumors in the brain and spinal cord.
In the late 1800s and early 1900s, doctors began describing tumors that seemed to arise from the lining of the fluid-filled spaces in the brain. At first, these growths were grouped in different ways because early pathology relied mostly on what could be seen under a microscope after surgery or autopsy. As medical science evolved, specialists became better at separating ependymomas from other brain tumors and at linking symptoms to the part of the brain involved, including the parietal lobe, where problems with sensation, spatial awareness, and certain thinking skills can stand out.
Over time, brain imaging changed the picture dramatically. Once CT and especially MRI became widely used, doctors could find parietal lobe ependymoma earlier and map its exact location before treatment. This helped explain why the early symptoms of parietal lobe ependymoma can vary so much from one person to another: some people develop headaches or seizures, while others first notice trouble with coordination, touch, or understanding space around them. Later research also showed that tumors that look similar under the microscope can behave differently, which led to more refined classification.
Today, the history of parietal lobe ependymoma is still being written. Researchers now combine imaging, pathology, and broader genetic testing to understand these tumors more clearly than in the past, even though the basic goal remains the same: to identify the tumor accurately and guide treatment as safely as possible. For many living with parietal lobe ependymoma, this long history matters because it has led to earlier diagnosis, more precise surgery, and a better understanding of what symptoms may mean in everyday life.